CDC releases 2026 Annual US Cancer Statistics Release
CDC’s latest United States Cancer Statistics release expands access to one of the nation’s most comprehensive cancer datasets, now including complete county-level cancer incidence data for all 50 states, the District of Columbia, and Puerto Rico.
The new data reveal that rural communities experienced higher cancer incidence rates than urban areas from 2019–2023, with approximately 467 ve…
Survey Highlights Persistent Uncertainty on STI Vaccines
A nationally representative Annenberg Public Policy Center survey found that while most U.S. adults understand core STI transmission routes, knowledge gaps persist around less common pathways and vaccine availability.
Majorities correctly identified gonorrhea, syphilis, chlamydia, HPV, and genital herpes as sexually transmitted, but far fewer recognized mpox (35%) or Zika (13%) as sexually tr…
Fake References in Medical Papers are Skyrocketing
A reference-integrity audit of 2.5 million biomedical papers and 125.6 million references in PubMed Central identified 4,046 fabricated references across 2,810 papers after multi-database verification and filtering.
Fabrication rates rose markedly, from 1 in 2,828 papers in 2023 to 1 in 458 in 2025, a more than 12-fold increase overall. Most affected papers contained one or two fabricated ref…
The Condition PCOS is Now Called PMOS
Researchers and clinicians have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the condition’s broader hormonal and metabolic impacts and improve patient care.
Affecting an estimated 1 in 8 women worldwide, the condition is associated with irregular menstrual cycles, elevated androgen levels, infertility, and increased risk of Type 2 diabetes, heart disease, and stroke. Experts say the previous name contributed to confusion, missed diagnoses, and limited understanding of the disorder beyond ovarian symptoms.
The updated term…
Fruit-Flavored E-cigarettes for Adults OK'd By FDA
The FDA authorized its first fruit-flavored e-cigarettes for adult smokers, marking a significant shift in federal vaping policy amid declining youth vaping rates, which are now at a 10-year low. The newly authorized products include mango and blueberry flavors and incorporate smartphone-based age verification and Bluetooth access controls intended to reduce youth access.
FDA officials emphasized that authorization is not an endorsement and stated the agency will monitor youth uptake and marketing practices closely.
The decision follows years of FDA denials for flavored products and ong…